Epidemiology and genetics of stroke and its subtypes

Publications

2007

Sudlow, C; Mason, G; Hankey, G Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients The Cochrane Database of Systematic Reviews (In press) 2007

2006

Jackson, CA; Sudlow, CL Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? Journal of Neurology Neurosurgery and Psychiatry 77 11 p1244-1252 2006 abstract Martinez-Gonzalez, NA; Sudlow, CL
Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage Journal of Neurology Neurosurgery and Psychiatry 77 12 p1329-1335 2006 abstract
Sudlow, C; Martinez Gonzalez, NA; Kim, J; Clark, C Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls Stroke 37 2 p364-370 2006 abstract

2005

Barnes, P; Hughes, R; Lecky, B; McCrone, P; Misbah, S; Newman, P; Palace, J; Price, R; Sudlow, C Association of British Neurologists guidelines for the use of intravenous immunoglubulin in neurological diseases 2005
Jackson, C; Sudlow, C Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts Stroke 36 4 p891-901 2005
Jackson, C; Sudlow, C Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction Brain 128 Pt 11 p2507-17 2005
Sudlow, C Survival after stroke in south London is apparently higher in black patients than in white ones BMJ 331 7514 p414-415 2005
Sudlow, C What is the role of dipyridamole in long-term secondary prevention after an ischaemic stroke or transient ischaemic attack? Canadian Med Assoc J 173 9 p1024-1026 2005

2004

Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R Technology assessment report commissioned by the HTA programme on behalf of the National Institute for Clinical Excellence. A rapid and systematic review of the clinical effectiveness and cost effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events Health Technol Assess 8 38 p1–210 2004
Main, C; Palmer, S; Griffin, S; Jones, L; Orton, V; Sculpher, M; Henderson, R; Sudlow, C; Hawkins, N; Riemsma, R Technology assessment report commissioned by the HTA programme on behalf of the National Institute for Clinical Excellence. A rapid and systematic review of the clinical effectiveness and cost effectiveness of clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segement-elevation acute coronary syndromes Health Technol Assess 8 40 p1–156 2004
Sudlow, CL Epilepsy and stroke Lancet 363 9416 p1175-1176 2004 Sudlow, C; Warlow, C, Edited by: Mohr JP, CD, Grotta JC, Weir B, Wolf PA, The long term medical management of patients with ischemic stroke and transient ischemic attack due to arterial disease, In book: Stroke: Pathophysiology, Diagnosis and Management (Fourth Edition) Philadelphia 2004

2003

Sudlow, CL; Counsell, CE Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis BMJ 326 7385 p388-92 2003
Warlow, C; Sudlow, C; Dennis, M; Wardlaw, J; Sandercock, P Stroke Lancet 362 9391 p1211-24 2003

2002

Baigent, C; Sudlow, C; Collins, R; Peto, R; Collaboration, obotAT Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 p71-86 2002
Goadsby, PJ; Boes, C; Sudlow, CLM Low CSF volume (pressure) headache Practical Neurology 2 p192-197 2002
Sudlow, CLM; Hankey, GJ Antiplatelet drugs in the secondary prevention of stroke Practical Neurology 2 p12-25 2002

1999 - 2006

Sudlow, C, Edited by: Tovey, D Stroke prevention: blood pressure reduction, cholesterol reduction, and antithrombotic treatment, In book: Clinical Evidence, Issues 1-16 London Revised and rewritten for updates eight monthly 1999-2006
Sudlow, C, Edited by: Barton, S Primary prevention of cardiovascular disease: antiplatelet and anticoagulant drugs, In book: Clinical Evidence, Issues 1-10 London Revised and rewritten for updates six monthly 1999-2003.
Sudlow, C, Edited by: Barton, S Secondary prevention of ischaemic cardiac events: antiplatelet and anticoagulant drugs, In book: Clinical Evidence, Issues 1-10 London Revised and rewritten for updates six monthly 1999-2003.

	Introduction Stroke Genetics Publications Contact	Epidemiology and genetics of stroke and its subtypes Publications 2007 Sudlow, C; Mason, G; Hankey, G Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients The Cochrane Database of Systematic Reviews (In press) 2007 2006 Jackson, CA; Sudlow, CL Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage? Journal of Neurology Neurosurgery and Psychiatry 77 11 p1244-1252 2006 abstract Martinez-Gonzalez, NA; Sudlow, CL Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage Journal of Neurology Neurosurgery and Psychiatry 77 12 p1329-1335 2006 abstract Sudlow, C; Martinez Gonzalez, NA; Kim, J; Clark, C Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls Stroke 37 2 p364-370 2006 abstract 2005 Barnes, P; Hughes, R; Lecky, B; McCrone, P; Misbah, S; Newman, P; Palace, J; Price, R; Sudlow, C Association of British Neurologists guidelines for the use of intravenous immunoglubulin in neurological diseases 2005 Jackson, C; Sudlow, C Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts Stroke 36 4 p891-901 2005 Jackson, C; Sudlow, C Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction Brain 128 Pt 11 p2507-17 2005 Sudlow, C Survival after stroke in south London is apparently higher in black patients than in white ones BMJ 331 7514 p414-415 2005 Sudlow, C What is the role of dipyridamole in long-term secondary prevention after an ischaemic stroke or transient ischaemic attack? Canadian Med Assoc J 173 9 p1024-1026 2005 2004 Jones, L; Griffin, S; Palmer, S; Main, C; Orton, V; Sculpher, M; Sudlow, C; Henderson, R; Hawkins, N; Riemsma, R Technology assessment report commissioned by the HTA programme on behalf of the National Institute for Clinical Excellence. A rapid and systematic review of the clinical effectiveness and cost effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events Health Technol Assess 8 38 p1–210 2004 Main, C; Palmer, S; Griffin, S; Jones, L; Orton, V; Sculpher, M; Henderson, R; Sudlow, C; Hawkins, N; Riemsma, R Technology assessment report commissioned by the HTA programme on behalf of the National Institute for Clinical Excellence. A rapid and systematic review of the clinical effectiveness and cost effectiveness of clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segement-elevation acute coronary syndromes Health Technol Assess 8 40 p1–156 2004 Sudlow, CL Epilepsy and stroke Lancet 363 9416 p1175-1176 2004 Sudlow, C; Warlow, C, Edited by: Mohr JP, CD, Grotta JC, Weir B, Wolf PA, The long term medical management of patients with ischemic stroke and transient ischemic attack due to arterial disease, In book: Stroke: Pathophysiology, Diagnosis and Management (Fourth Edition) Philadelphia 2004 2003 Sudlow, CL; Counsell, CE Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis BMJ 326 7385 p388-92 2003 Warlow, C; Sudlow, C; Dennis, M; Wardlaw, J; Sandercock, P Stroke Lancet 362 9391 p1211-24 2003 2002 Baigent, C; Sudlow, C; Collins, R; Peto, R; Collaboration, obotAT Collaborative meta-analysis of randomised trials of antiplatelet therapy for the prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 p71-86 2002 Goadsby, PJ; Boes, C; Sudlow, CLM Low CSF volume (pressure) headache Practical Neurology 2 p192-197 2002 Sudlow, CLM; Hankey, GJ Antiplatelet drugs in the secondary prevention of stroke Practical Neurology 2 p12-25 2002 1999 - 2006 Sudlow, C, Edited by: Tovey, D Stroke prevention: blood pressure reduction, cholesterol reduction, and antithrombotic treatment, In book: Clinical Evidence, Issues 1-16 London Revised and rewritten for updates eight monthly 1999-2006 Sudlow, C, Edited by: Barton, S Primary prevention of cardiovascular disease: antiplatelet and anticoagulant drugs, In book: Clinical Evidence, Issues 1-10 London Revised and rewritten for updates six monthly 1999-2003. Sudlow, C, Edited by: Barton, S Secondary prevention of ischaemic cardiac events: antiplatelet and anticoagulant drugs, In book: Clinical Evidence, Issues 1-10 London Revised and rewritten for updates six monthly 1999-2003.
	Updated: Wed, 22nd September, 2010